Rachid Rafia

Publication Activity (10 Years)

Years Active: 2017-2020
Publications (10 Years): 4

Top Topics

Early Breast Cancer

Systematic Review

Health Information

Top Venues

PharmacoEconomics

Health technology assessment (Winchester, England)

University of sheffield

Sorbonne University (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of sheffield Feb 01 2008

United Kingdom

Research Fellow in Health economics :: HEDS

Education History

Sorbonne University Sep 01 2004 - Dec 31 2005

France

MSC

Publications

Sarah Davis, Rachid Rafia, Christopher Carroll, Jean Hamilton, Munira Essat
Pirfenidone for Treating Idiopathic Pulmonary Fibrosis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics 37 (6) (2020)
S E Harnan, Paul Tappenden, Katy Cooper, John W Stevens, Alice Bessey, Rachid Rafia, Sue E Ward, Ruth Wong, Robert C Stein, Janet Brown
Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer: a systematic review and economic analysis. Health technology assessment (Winchester, England) 23 (30) (2020)
Rachid Rafia, Abdullah Pandor, Sarah Davis, John W Stevens, Sue Harnan, Mark Clowes, Youssef Sorour, Robert Cutting
Obinutuzumab with Bendamustine for Treating Follicular Lymphoma Refractory to Rituximab: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics 36 (10) (2019)
Rachid Rafia, Alison Scope, Sue Harnan, John W Stevens, Matt Stevenson, Alan Lobo
Vedolizumab for Treating Moderately to Severely Active Crohn's Disease After Prior Therapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics 34 (12) (2017)